Providers' perceptions of parental concerns about HPV vaccination

Journal of Health Care for the Poor and Underserved

Volumn 24, Issue 2, 2013, Pages 828-839

  Perkins, Rebecca B ^a   Clark, Jack A ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

HPV vaccine; Patient provider communication; Provider attitudes; Underserved populations

Indexed keywords

EID: 84878438887     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2013.0080     Document Type: Article

References (29)

1. HealthyPeople. gov. Cancer. Washington, DC: U.S. Department of Health and Human Services, 2012. Available at: http://healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=5.
2. National Cancer Institute, Surveillance Epidemiology and End Results (SEER). SEER Stat Fact Sheets: Cervix Uteri. Bethesda, MD: National Cancer Institute, U.S. National Institutes of Health, 2012. Available at: http://seer.cancer.gov/statfacts/html/cervix.html#incidence-mortality.
3. Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol 2007 Jul;110(1):87-95.
4. Goel MS, Wee CC, McCarthy EP, et al. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003 Dec;18(12):1028-35.
5. Markowitz LE, Dunne EF, Saraiya M, et al, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2007 Mar 23;56(No RR-2):1-24.
6. Clifford G, Franceschi S, Diaz M, et al. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006 Aug 31;24 Suppl 3:S3/26-34.
7. Flannery B, Schrag S, Bennett NM, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA. 2004 May;291(18): 2197-203.
8. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005 May;6(5):271-8.
9. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13 through 17 Years-United States, 2010. MMWR Morb Mortal Wkly Rep. 2011 Aug;60(33):1117-23.
10. Cook RL, Zhang J, Mullins J, et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010 Dec;47(6):596-9.
11. Daley EM, Vamos CA, Buhi ER, et al. Influences on human papillomavirus vaccination status among female college students. J Womens Health (Larchmt). 2010 Oct;19(10):1885-91.
12. Guerry SL, De Rosa CJ, Markowitz LE, et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine. 2011 Mar;29(12):2235-41.
13. McCave EL. Influential factors in HPV vaccination uptake among providers in four states. J Community Health. 2010 Dec;35(6):645-52.
14. Kahn JA, Rosenthal SL, Tissot AM, et al. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr. 2007 Sep-Oct; 7(5):367-73.
15. Schnatz PF, Humphrey K, O'Sullivan DM. Assessment of the perceptions and administration of the human papillomavirus vaccine. J Low Genit Tract Dis. 2010 Apr;14(2):103-7.
16. Young JL, Bernheim RG, Korte JE, et al. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol. 2011 Dec;24(6):380-5.
17. Askelson NM, Campo S, Lowe JB, et al. Factors related to physicians' willingness to vaccinate girls against HPV: the importance of subjective norms and perceived behavioral control. Women Health. 2010 Mar;50(2):144-58.
18. Jensen ME, Hartenbach E, McElroy JA, et al. Brief report: Measuring the attitudes of health care professionals in Dane County toward adolescent immunization with HPV vaccine. WMJ. 2009 Jul;108(4):203-5.
19. Tariq S, Bhakta S, Grimes A, et al. Attitudes of Arkansas' primary care physicians toward the HPV vaccine. J Ark Med Soc. 2009 Nov;106(5):113-7.
20. Smith MJ, Woods CR, Marshall GS. Parental vaccine concerns in Kentucky. J Ky Med Assoc. 2009 Seo;107(9):342-9.
21. Sussman AL, Helitzer D, Sanders M, et al. HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care. Ann Fam Med. 2007 Jul-Aug;5(4):298-304.
22. Tissot AM, Zimet GD, Rosenthal SL, et al. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health. 2007 Aug;41(2):119-25.
23. Perkins RB, Pierre-Joseph N, Marquez C, et al. Why do low-income minority parents choose human papillomavirus vaccination for their daughters? J Pediatr. 2010 Oct;157(4):617-22.
24. Perkins RB, Pierre-Jospeh N, Marquez C, et al. Parents' opinions of mandatory human papillomavirus vaccination: does ethnicity matter? Womens Health Issues. 2010 Nov-Dec;20(6):420-6.
25. Ajzen I. From intentions to actions: A theory of planned behavior. In: Kuhl J, Beckman J, eds. Action-control: From cognition to behavior. Heidelberg, Germany: Springer, 1985.
26. Charmaz K. Constructing grounded theory: A practical guide through qualitative analysis. Thousand Oaks, CA: Sage Publications, 2006.
27. Slade BA, Leidel L, Vellozzi C, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA. 2009 Aug;302(7):750-7.
28. Block SL, Brown DR, Chatterjee A, et al. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine. Pediatr Infect Dis J. 2010 Feb;29(2):95-101.
29. Trottier H, Burchell AN. Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genomics. 2009;12(5-6):291-307.